|
Sanchez-Villalobos M, Campos Banos E, Juan Fita MJ, Egea Mellado JM, Gonzalez Gallego I, Beltran Videla A, Berenguer Piqueras M, Bermudez Cortes M, Moraleda Jimenez JM, Guillen Navarro E, Salido Fierrez E, Perez-Oliva AB. A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain). Int J Neonatal Screen. 2023 Oct 10;9(4):55. doi: 10.3390/ijns9040055. PubMed PMID: 37873846; PubMed Central PMCID: PMC10594431.
AÑO: 2023; IF: 3.5
|
37873846
|
Gomez-Abellan V, Perez-Oliva AB, Cabas I, Hermi F, Arizcun M, Garcia-Moreno D, Sepulcre MP, Mulero V. Peroxisome proliferator-activated receptors alpha and beta mediate the anti-inflammatory effects of the cyclopentenone prostaglandin 15-deoxy-Delta12,14-PGJ2 in fish granulocytes. Dev Comp Immunol. 2022 Nov;136:104498. doi: 10.1016/j.dci.2022.104498. Epub 2022 Aug 7. PubMed PMID: 35948178.
AÑO: 2022; IF: 2.9
|
|
Sanchez-Villalobos M, Blanquer M, Moraleda JM, Salido EJ, Perez-Oliva AB. New Insights Into Pathophysiology of beta-Thalassemia. Front Med (Lausanne). 2022 Apr 12;9:880752. doi: 10.3389/fmed.2022.880752. eCollection 2022. PubMed PMID: 35492364; PubMed Central PMCID: PMC9041707.
AÑO: 2022; IF: 5.058
|
|
Fatas-Lalana B, Canton-Sandoval J, Rodriguez-Ruiz L, Corbalan-Velez R, Martinez-Menchon T, Perez-Oliva AB, Mulero V. Impact of Comorbidities of Patients with Psoriasis on Phototherapy Responses. Int J Mol Sci. 2022 Aug 23;23(17):9508. doi: 10.3390/ijms23179508. PubMed PMID: 36076906; PubMed Central PMCID: PMC9455671.
AÑO: 2022; IF: 5.6
|
|
Nanda SK, Vollmer S, Perez-Oliva AB. Posttranslational Regulation of Inflammasomes, Its Potential as Biomarkers and in the Identification of Novel Drugs Targets. Front Cell Dev Biol. 2022 Jun 21;10:887533. doi: 10.3389/fcell.2022.887533. eCollection 2022. PubMed PMID: 35800898; PubMed Central PMCID: PMC9253692.
AÑO: 2022; IF: 5.5
|